Abbott’s remote heart failure monitoring system reduces hospitalizations in clinical trial

In a clinical trial, Abbott's remote heart failure monitoring system increased quality of life and decreased heart failure hospitalizations. The information was obtained from a trial in which 348 participants were randomly assigned to receive standard care or monitoring using Abbott's CardioMEMS gadget. The device was associated in the trial with a 44% decrease in hospitalizations for heart failure. The clinical trial was carried out by Dutch researchers to address the paucity of data regarding the usage of the device in Europe. This research is the third randomized, controlled trial conducted worldwide that has found a significant health benefit for CardioMEMS.

A paperclip-sized sensor that is implanted in the pulmonary artery makes up CardioMEMS. Once installed, the sensor keeps track of pulmonary artery pressure and provides alerts if anything changes.